Ocean Biomedical is a new-generation American biopharmaceutical company based in

Providence, Rhode Island Providence () is the List of capitals in the United States, capital and List of municipalities in Rhode Island, most populous city of the U.S. state of Rhode Island. The county seat of Providence County, Rhode Island, Providence County, it is o ...

. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician

Chirinjeev Kathuria Chirinjeev Kathuria is an Indian-American investor, physician, politician, businessperson, and philanthropist. He was the first Indian-American to run for the US Senate. Kathuria was the co-founder and co-chairman of UpHealth Inc. which went pub ...

with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.

History

In January 2019

co-founded Ocean Biomedical in

Rhode Island Rhode Island ( ) is a state in the New England region of the Northeastern United States. It borders Connecticut to its west; Massachusetts to its north and east; and the Atlantic Ocean to its south via Rhode Island Sound and Block Is ...

, United States. The company was also co-founded by Jack Elias, who was Dean of Medicine at

Brown University Brown University is a Private university, private Ivy League research university in Providence, Rhode Island, United States. It is the List of colonial colleges, seventh-oldest institution of higher education in the US, founded in 1764 as the ' ...

at the time, but currently works as a senior health advisor at Brown. Ocean Biomedical started off as a Brown University biotech "spin-off." The biopharmaceutical company is currently based in Province, Rhode Island. As of 2021 the CEO of the company is Elizabeth Ng. The company works with scientists and research institutions around the world on the research and development projects for new medicines. In 2021 Ocean Biomedical announced plans to go public and filed for a $100 million,the only known investor is Alan Mendosa Campos.

Areas

Ocean Biomedical has worked in areas such as

non-small cell lung cancer Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitiv ...

and

pulmonary fibrosis Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory ...

Vaccines

Ocean Biomedical has worked on developing vaccines for tropical diseases such as

malaria Malaria is a Mosquito-borne disease, mosquito-borne infectious disease that affects vertebrates and ''Anopheles'' mosquitoes. Human malaria causes Signs and symptoms, symptoms that typically include fever, Fatigue (medical), fatigue, vomitin ...

, as well as for emerging diseases like

COVID-19 Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever ...

. In 2020, the company announced the discovery of a

malaria vaccine Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which affected an estimated 249 million people globally in 85 malaria-endemic countries and areas and caused 608,000 deaths in 2022. The first approved vac ...

Affiliations and partnerships

Ocean Biomedical also has partnered with scientists such as: *Jack Elias (Dean of Biology and Medicine of

Alpert Medical School The Warren Alpert Medical School (formerly known as Brown Medical School, previously known as Brown University School of Medicine) is the medical school of Brown University, located in Providence, Rhode Island. Originally established in 1811, it ...

) *Jake Kurtis (Chair of Pathology and Laboratory Medicine,

) Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster.

References

External links

LinkedIn
{{Authority control Companies based in Providence, Rhode Island Pharmaceutical companies of the United States Brown University organizations